Hester Biosciences Limited (NSE:HESTERBIO)
India
· Delayed Price · Currency is INR | Market Cap | 14.97B |
| Revenue (ttm) | 3.15B |
| Net Income (ttm) | 274.88M |
| Shares Out | n/a |
| EPS (ttm) | 33.89 |
| PE Ratio | 54.48 |
| Forward PE | n/a |
| Dividend | 6.00 (0.33%) |
| Ex-Dividend Date | Aug 22, 2024 |
| Volume | 4,013 |
| Average Volume | 10,422 |
| Open | 1,776.90 |
| Previous Close | 1,760.00 |
| Day's Range | 1,730.00 - 1,780.50 |
| 52-Week Range | 1,242.95 - 3,379.00 |
| Beta | 0.18 |
| RSI | 52.71 |
| Earnings Date | May 16, 2025 |
About Hester Biosciences
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, marek’s disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucella abortus, cont... [Read more]
Financial Performance
In 2024, Hester Biosciences's revenue was 3.15 billion, an increase of 1.23% compared to the previous year's 3.11 billion. Earnings were 274.88 million, an increase of 45.52%.
Financial StatementsNews
India's Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc.
Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 06, 2025 (GLOBE NEWSWIRE) -- The India animal healthcare market is experiencing significant growth, driven by a rising livestock popula...